[vc_row][vc_column width=”1/2″][vc_column_text]Discovery Park – and some of the businesses driving its success – used one of the UK’s leading science events, Genesis 2018, to launch Building 518 – the latest building to be brought gradually back into use onsite. The management team were on hand to showcase why Discovery Park remains the perfect location for science companies looking to grow and collaborate and, with several of its life sciences tenants, showcased its activities and discussed plans for the future development of the Park.
Building 518 is a high-grade manufacturing facility that is well-suited to GMP accreditation of pilot scale (small molecule) drug development. Previously occupied by a global manufacturer of respiratory medicines, the facility was used to supply patients around the world. It forms part of the Discovery Park vision to become a world leading centre of excellence in advanced manufacturing.
Discovery Park is a thriving part of South East England’s life science community with high quality laboratory, office and manufacturing space, access to local finance and a strong scientific talent pool. A multi-business site since 2012, Discovery Park was formerly the European R&D headquarters of Pfizer and benefits from that scientific heritage. Pfizer retains a strong and growing presence on the Park.[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_single_image image=”5978″][vc_single_image image=”5979″][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]A4P Bio, Canterbury Christ Church University’s School of Life Sciences, Centauri Therapeutics, Concept Life Sciences, EligoChem Ltd, Jaytee Bioscience Ltd, Project Fusion, Scitegrity, TRN, Venomtech and Wren Healthcare will join Discovery Park and Kent’s inward investment agency Locate In Kent at the conference. This event takes place at the QEII Centre in Westminster, London on Thursday, 13 December. Delegates will be able to find the Discovery Park village at Stands 15 and 16.
Mayer Schreiber, CEO of Discovery Park, said: “Discovery Park is a thriving part of the South East’s life science community, driven in no small part by the success of our tenants. I’m delighted that we’ll be able to share the stage at Genesis with many of those companies. With high quality space available now and ambitious plans for expansion of the Park, we look forward to welcoming more innovative companies as tenants over 2019.”[/vc_column_text][/vc_column][/vc_row]